CSIMarket
 
Billiontoone Inc   (NASDAQ: BLLN)
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 

Billiontoone Inc's Customers Performance

BLLN



 
BLLN's Source of Revenues During the corresponding time, Billiontoone Inc recorded a revenue increase by 83.33 % year on year, sequentially revenue fell by -51.22 %. While revenue at the Billiontoone Inc 's corporate clients

List of BLLN Customers




for the same period Billiontoone Inc recorded revenue increase by 83.33 % year on year, sequentially revenue fell by -51.22 %.

List of BLLN Customers

Billiontoone Inc's Business Units
Prenatal    89.3 % of total Revenue
Oncology    9.92 % of total Revenue
Clinical trial support and other services    1.06 % of total Revenue






Billiontoone Inc's Comment on Sales, Marketing and Customers



The company provides services to clinics expanding in existing and new territories. Its market focuses on molecular diagnostics and precision medicine through the detection and analysis of cell-free DNA (cfDNA). The company targets conditions detectable via cfDNA, including late-stage cancer, requiring ultrasensitive quantification at the single-molecule level. This capability is enabled by its proprietary single-molecule next-generation sequencing (smNGS) platform. The market segments served include molecular diagnostics companies and precision medicine applications involving cfDNA analysis for disease diagnosis and monitoring.





Billiontoone Inc’s Comment on Sales, Marketing and Customers


The company provides services to clinics expanding in existing and new territories. Its market focuses on molecular diagnostics and precision medicine through the detection and analysis of cell-free DNA (cfDNA). The company targets conditions detectable via cfDNA, including late-stage cancer, requiring ultrasensitive quantification at the single-molecule level. This capability is enabled by its proprietary single-molecule next-generation sequencing (smNGS) platform. The market segments served include molecular diagnostics companies and precision medicine applications involving cfDNA analysis for disease diagnosis and monitoring.








BLLN's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Billiontoone Inc 5,270.49 0.00 0.00 713
SUBTOTAL 0.00 0.00 0.00 -

Sources: Billiontoone Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Billiontoone Inc’s corporate clients.
For your research, we’ve provided 9 tables on Billiontoone Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.